Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

BGICC 2021

21 - 22 Jan 2021

Hilton Heliopolis, Cairo, Egypt

UICC Breast Cancer Programme: update and opportunities

Sabrina Zucchello - Grants Manager, UICC

UICC Breast Cancer Programme: update and opportunities ( Sabrina Zucchello - Grants Manager, UICC )

ERAS in gynaecological oncology from developed to developing countries

Prof Geetu Bhandoria - Command Hospital, Kolkata, India

ERAS in gynaecological oncology from developed to developing countries ( Prof Geetu Bhandoria - Command Hospital, Kolkata, India )

New tools that can be used in clinical practice to make better decisions for women with early breast cancer

Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium

New tools that can be used in clinical practice to make better decisions for women with early breast cancer ( Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium )

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC

Prof Hope Rugo - University of California San Francisco, San Francisco, USA

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )

Re-irradiation in breast cancer

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Re-irradiation in breast cancer ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

Postmastectomy radiation therapy in breast cancer patients who had immediate reconstruction

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Postmastectomy radiation therapy in breast cancer patients who had immediate reconstruction ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

Current treatment standards for primary ovarian cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA

Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )

Evolving medical treatment in advanced/recurrent endometrial cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA

Evolving medical treatment in advanced/recurrent endometrial cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )

Management of breast cancer recurrence

Dr Mehra Golshan - Yale School of Medicine, New Haven, USA

Management of breast cancer recurrence ( Dr Mehra Golshan - Yale School of Medicine, New Haven, USA )

Neo-adjuvant therapy and surgical decision making in breast cancer

Dr Mehra Golshan - Yale School of Medicine, New Haven, USA

Neo-adjuvant therapy and surgical decision making in breast cancer ( Dr Mehra Golshan - Yale School of Medicine, New Haven, USA )

Updates on managing HER2-positive early breast cancer

Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain

Updates on managing HER2-positive early breast cancer ( Dr Javier Cortes - Vall d’Hebron University Hospital, Barcelona, Spain )

Managing HER2-positive breast cancer

Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA

Managing HER2-positive breast cancer ( Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA )

Management of axilla after neo-adjuvant treatment

Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA

Management of axilla after neo-adjuvant treatment ( Prof Monica Morrow - Memorial Sloan Kettering Cancer Center, New York, USA )

Highlights from BGICC 2021

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from BGICC 2021 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Escalation and descalation in neoadjuvant time to treatment of TNBC

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Escalation and descalation in neoadjuvant time to treatment of TNBC ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

A new way of thinking on the origin of breast cancer and how early breast cancer should be treated

Prof László Tabár - University of Uppsala, Uppsala, Sweden

A new way of thinking on the origin of breast cancer and how early breast cancer should be treated ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )

The history of breast cancer diagnosis

Prof László Tabár - University of Uppsala, Uppsala, Sweden

The history of breast cancer diagnosis ( Prof László Tabár - University of Uppsala, Uppsala, Sweden )

Recent therapies for HER2 advanced breast cancer

Dr Sandra Swain - Georgetown University, Washington DC, USA

Recent therapies for HER2 advanced breast cancer ( Dr Sandra Swain - Georgetown University, Washington DC, USA )

BRCA mutation in metastatic TNBC patients

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon

BRCA mutation in metastatic TNBC patients ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )

Pre-operative staging with breast MRI

Dr Supriya Kulkarni - University of Toronto, Toronto, Canada

Pre-operative staging with breast MRI ( Dr Supriya Kulkarni - University of Toronto, Toronto, Canada )

Imaging of lobular carcinoma

Dr Supriya Kulkarni - University of Toronto, Toronto, Canada

Imaging of lobular carcinoma ( Dr Supriya Kulkarni - University of Toronto, Toronto, Canada )

Breast cancer surveillance

Dr Supriya Kulkarni - University of Toronto, Toronto, Canada

Breast cancer surveillance ( Dr Supriya Kulkarni - University of Toronto, Toronto, Canada )

Is chemotherapy only a treatment of last resort in luminal breast cancers?

Prof David Cameron - University of Edinburgh, Edinburgh, UK

Is chemotherapy only a treatment of last resort in luminal breast cancers? ( Prof David Cameron - University of Edinburgh, Edinburgh, UK )

Challenges in oncology management during the COVID-19 era

Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland

Challenges in oncology management during the COVID-19 era ( Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland )

Updates on criteria for patient selection and surgical management in advanced ovarian cancer

Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA

Updates on criteria for patient selection and surgical management in advanced ovarian cancer ( Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA )

More from ecancer